Table of Content

Table of Contents

Global Peptide Therapeutics Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Peptide Therapeutics Market by Value
2.2.1 Global Peptide Therapeutics Revenue by Type
2.2.2 Global Peptide Therapeutics Market by Value (%)
2.3 Global Peptide Therapeutics Market by Production
2.3.1 Global Peptide Therapeutics Production by Type
2.3.2 Global Peptide Therapeutics Market by Production (%)

3. The Major Driver of Peptide Therapeutics Industry
3.1 Historical & Forecast Global Peptide Therapeutics Demand
3.2 Largest Application for Peptide Therapeutics (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Peptide Therapeutics Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Peptide Therapeutics Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Peptide Therapeutics Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Peptide Therapeutics Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Peptide Therapeutics Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Peptide Therapeutics Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Peptide Therapeutics Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Peptide Therapeutics Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Peptide Therapeutics Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Peptide Therapeutics Average Price Trend
12.1 Market Price for Each Type of Peptide Therapeutics in US (2018-2022)
12.2 Market Price for Each Type of Peptide Therapeutics in Europe (2018-2022)
12.3 Market Price for Each Type of Peptide Therapeutics in China (2018-2022)
12.4 Market Price for Each Type of Peptide Therapeutics in Japan (2018-2022)
12.5 Market Price for Each Type of Peptide Therapeutics in India (2018-2022)
12.6 Market Price for Each Type of Peptide Therapeutics in Korea (2018-2022)
12.7 Market Price for Each Type of Peptide Therapeutics in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Peptide Therapeutics Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Peptide Therapeutics

14. Peptide Therapeutics Competitive Landscape
14.1 Pfizer
14.1.1 Pfizer Company Profiles
14.1.2 Pfizer Product Introduction
14.1.3 Pfizer Peptide Therapeutics Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Eli Lilly and Company
14.2.1 Eli Lilly and Company Company Profiles
14.2.2 Eli Lilly and Company Product Introduction
14.2.3 Eli Lilly and Company Peptide Therapeutics Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Bachem Holding
14.3.1 Bachem Holding Company Profiles
14.3.2 Bachem Holding Product Introduction
14.3.3 Bachem Holding Peptide Therapeutics Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Amgen
14.4.1 Amgen Company Profiles
14.4.2 Amgen Product Introduction
14.4.3 Amgen Peptide Therapeutics Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Roche
14.5.1 Roche Company Profiles
14.5.2 Roche Product Introduction
14.5.3 Roche Peptide Therapeutics Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 GlaxoSmithKline
14.6.1 GlaxoSmithKline Company Profiles
14.6.2 GlaxoSmithKline Product Introduction
14.6.3 GlaxoSmithKline Peptide Therapeutics Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Novartis
14.7.1 Novartis Company Profiles
14.7.2 Novartis Product Introduction
14.7.3 Novartis Peptide Therapeutics Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Sanofi
14.8.1 Sanofi Company Profiles
14.8.2 Sanofi Product Introduction
14.8.3 Sanofi Peptide Therapeutics Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Takeda Pharmaceutical Company
14.9.1 Takeda Pharmaceutical Company Company Profiles
14.9.2 Takeda Pharmaceutical Company Product Introduction
14.9.3 Takeda Pharmaceutical Company Peptide Therapeutics Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Teva Pharmaceutical
14.10.1 Teva Pharmaceutical Company Profiles
14.10.2 Teva Pharmaceutical Product Introduction
14.10.3 Teva Pharmaceutical Peptide Therapeutics Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Peptide Therapeutics Industry (Volume)
Figure 2. Peptide Therapeutics Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Peptide Therapeutics Revenue in 2022
Figure 5. US Peptide Therapeutics Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Peptide Therapeutics Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Peptide Therapeutics Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Peptide Therapeutics Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Peptide Therapeutics Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Peptide Therapeutics Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Peptide Therapeutics Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Peptide Therapeutics Revenue, by Type (Million USD) (2018-2028)
Table 4. Peptide Therapeutics Production, by Type (K Unit) (2018-2028)
Table 5. Peptide Therapeutics Demand (K Unit) by Application (2018-2028)
Table 6. Peptide Therapeutics Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Peptide Therapeutics Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Peptide Therapeutics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Peptide Therapeutics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Peptide Therapeutics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Peptide Therapeutics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Peptide Therapeutics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Peptide Therapeutics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Peptide Therapeutics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Peptide Therapeutics in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Peptide Therapeutics in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Peptide Therapeutics in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Peptide Therapeutics in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Peptide Therapeutics in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Peptide Therapeutics in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Peptide Therapeutics in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Pfizer Profiles
Table 61. Pfizer Peptide Therapeutics Product Introduction
Table 62. Pfizer Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Pfizer Strategic initiatives
Table 64. Eli Lilly and Company Profiles
Table 65. Eli Lilly and Company Peptide Therapeutics Product Introduction
Table 66. Eli Lilly and Company Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Eli Lilly and Company Strategic initiatives
Table 68. Bachem Holding Profiles
Table 69. Bachem Holding Peptide Therapeutics Product Introduction
Table 70. Bachem Holding Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Bachem Holding Strategic initiatives
Table 72. Amgen Profiles
Table 73. Amgen Peptide Therapeutics Product Introduction
Table 74. Amgen Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Amgen Strategic initiatives
Table 76. Roche Profiles
Table 77. Roche Peptide Therapeutics Product Introduction
Table 78. Roche Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Roche Strategic initiatives
Table 80. GlaxoSmithKline Profiles
Table 81. GlaxoSmithKline Peptide Therapeutics Product Introduction
Table 82. GlaxoSmithKline Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. GlaxoSmithKline Strategic initiatives
Table 84. Novartis Profiles
Table 85. Novartis Peptide Therapeutics Product Introduction
Table 86. Novartis Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Novartis Strategic initiatives
Table 88. Sanofi Profiles
Table 89. Sanofi Peptide Therapeutics Product Introduction
Table 90. Sanofi Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Sanofi Strategic initiatives
Table 92. Takeda Pharmaceutical Company Profiles
Table 93. Takeda Pharmaceutical Company Peptide Therapeutics Product Introduction
Table 94. Takeda Pharmaceutical Company Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Takeda Pharmaceutical Company Strategic initiatives
Table 97. Teva Pharmaceutical Profiles
Table 98. Teva Pharmaceutical Peptide Therapeutics Product Introduction
Table 99. Teva Pharmaceutical Peptide Therapeutics Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Teva Pharmaceutical Strategic initiatives